Cullinan Oncology, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    (estimated) €116.99M +507.3% -€217.09M -10.3% -185.6% +11 pp N/A N/A
    (estimated) €19.26M -44.6% -€241.96M +23.4% -1,256.0% -6.9 pp N/A N/A
    (estimated) €34.75M +11.8% -€196.14M +12.0% -564.4% -0.0094 pp N/A N/A
    (estimated) €31.08M +399.7% -€175.14M +2.5% -563.4% +22 pp N/A N/A
    (estimated) €6.22M +∞% -€170.85M +18.5% -2,746.7% -27 pp N/A N/A
    €0.00 +NaN% -€144.21M +9.3% N/A -€125.19M +8.4% N/A
    €0.00 +NaN% -€131.96M -237.7% N/A -€115.51M +6.8% N/A
    €0.00 -100.0% €95.82M -269.6% N/A -€108.15M +193.0% N/A
    €16.32M +∞% -€56.49M +26.6% -346.1% -3.5 pp -€36.91M +44.0% -226.2% -2.3 pp
    €0.00 +NaN% -€44.63M +158.5% N/A -€25.64M +42.6% N/A
    €0.00 +NaN% -€17.26M +41.2% N/A -€17.99M +57.1% N/A
    €0.00 -€12.22M N/A -€11.45M N/A

    Notifications